Paper8760804
The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.
Pende D and 9 others. J Exp Med, 1996. Cited by 314 papers, by iCite.
Cite this record
ConductScience Library. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. Papers, record 8760804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8760804
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HLA-A3 Antigen | Major topic |
| Killer Cells, Natural | Major topic |
| Receptors, Immunologic | Major topic |
| 3T3 Cells | |
| Amino Acid Sequence | |
| Animals | |
| Antibodies, Monoclonal | |
| Base Sequence | |
| Cloning, Molecular | |
| DNA Primers | |
| DNA, Complementary | |
| Disulfides | |
| Humans | |
| Macromolecular Substances | |
| Mice | |
| Molecular Sequence Data | |
| Receptors, KIR | |
| Receptors, KIR2DL3 |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8149950 | Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. | Eur J Immunol | 1994 | https://conductscience.org/library/papers/8149950 | PubMed |
| 2 | 8376937 | Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. | J Exp Med | 1993 | https://conductscience.org/library/papers/8376937 | PubMed |
| 3 | 8046333 | Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. | J Exp Med | 1994 | https://conductscience.org/library/papers/8046333 | PubMed |
| 4 | 7925558 | T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. | Eur J Immunol | 1994 | https://conductscience.org/library/papers/7925558 | PubMed |
| 5 | 7523145 | The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase. | Eur J Immunol | 1994 | https://conductscience.org/library/papers/7523145 | PubMed |
| 6 | 7716542 | Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. | Science | 1995 | https://conductscience.org/library/papers/7716542 | PubMed |
| 7 | 7716543 | Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. | Science | 1995 | https://conductscience.org/library/papers/7716543 | PubMed |
| 8 | 7749980 | Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. | Immunity | 1995 | https://conductscience.org/library/papers/7749980 | PubMed |
| 9 | 7629517 | Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. | J Exp Med | 1995 | https://conductscience.org/library/papers/7629517 | PubMed |
| 10 | 7650366 | Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. | J Immunol | 1995 | https://conductscience.org/library/papers/7650366 | PubMed |
| 11 | 7650491 | Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. | J Exp Med | 1995 | https://conductscience.org/library/papers/7650491 | PubMed |
| 12 | 7589107 | Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. | Eur J Immunol | 1995 | https://conductscience.org/library/papers/7589107 | PubMed |
| 13 | 7547697 | Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. | Int Immunol | 1995 | https://conductscience.org/library/papers/7547697 | PubMed |
| 14 | 8627176 | The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. | J Exp Med | 1996 | https://conductscience.org/library/papers/8627176 | PubMed |
| 15 | 8643653 | Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8643653 | PubMed |
| 16 | 8717527 | Receptors for HLA class-I molecules in human natural killer cells. | Annu Rev Immunol | 1996 | https://conductscience.org/library/papers/8717527 | PubMed |
| 17 | 2461560 | Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/2461560 | PubMed |
| 18 | 2683611 | Biology of natural killer cells. | Adv Immunol | 1989 | https://conductscience.org/library/papers/2683611 | PubMed |
| 19 | 2137855 | A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function. | J Exp Med | 1990 | https://conductscience.org/library/papers/2137855 | PubMed |
| 20 | 1694227 | Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells. | J Exp Med | 1990 | https://conductscience.org/library/papers/1694227 | PubMed |
Cited by85
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 314 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41188903 | Leveraging the heterogeneity of the NK cell repertoire for the development of immunotherapies for acute leukemia. | J Transl Med | 2025 | https://conductscience.org/library/papers/41188903 | PubMed |
| 39262781 | Exploring the role of KIR3DL2 on NK cells in hepatocellular carcinoma and its potential prognostic implications. | iScience | 2024 | https://conductscience.org/library/papers/39262781 | PubMed |
| 35911762 | Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C. | Front Immunol | 2022 | https://conductscience.org/library/papers/35911762 | PubMed |
| 35095867 | KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer. | Front Immunol | 2021 | https://conductscience.org/library/papers/35095867 | PubMed |
| 34760351 | Abundant CpG-sequences in human genomes inhibit KIR3DL2-expressing NK cells. | PeerJ | 2021 | https://conductscience.org/library/papers/34760351 | PubMed |
| 34272304 | Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma. | J Immunother Cancer | 2021 | https://conductscience.org/library/papers/34272304 | PubMed |
| 32804949 | Epistatic interactions between killer immunoglobulin-like receptors and human leukocyte antigen ligands are associated with ankylosing spondylitis. | PLoS Genet | 2020 | https://conductscience.org/library/papers/32804949 | PubMed |
| 32213565 | Two Lineages of KLRA with Contrasting Transcription Patterns Have Been Conserved at a Single Locus during Ruminant Speciation. | J Immunol | 2020 | https://conductscience.org/library/papers/32213565 | PubMed |
| 31337191 | Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study | Turk J Haematol | 2019 | https://conductscience.org/library/papers/31337191 | PubMed |
| 31231370 | Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation. | Front Immunol | 2019 | https://conductscience.org/library/papers/31231370 | PubMed |
| 29930758 | Prognostic values of the mRNA expression of natural killer receptor ligands and their association with clinicopathological features in breast cancer patients. | Oncotarget | 2018 | https://conductscience.org/library/papers/29930758 | PubMed |
| 29358179 | Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation. | Blood | 2018 | https://conductscience.org/library/papers/29358179 | PubMed |
| 29263215 | Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. | J Immunol | 2018 | https://conductscience.org/library/papers/29263215 | PubMed |
| 29032460 | The impact of KIR-HLA genotype on hepatitis B virus clearance in Iranian infected individuals. | Med Microbiol Immunol | 2017 | https://conductscience.org/library/papers/29032460 | PubMed |
| 28912774 | Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas. | Front Immunol | 2017 | https://conductscience.org/library/papers/28912774 | PubMed |
| 28659916 | HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy. | Front Immunol | 2017 | https://conductscience.org/library/papers/28659916 | PubMed |
| 27490240 | KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease. | PLoS One | 2016 | https://conductscience.org/library/papers/27490240 | PubMed |
| 26874942 | Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies. | Cancer Immunol Immunother | 2016 | https://conductscience.org/library/papers/26874942 | PubMed |
| 26013798 | Practical NK cell phenotyping and variability in healthy adults. | Immunol Res | 2015 | https://conductscience.org/library/papers/26013798 | PubMed |
| 25582852 | The D0 Ig-like domain plays a central role in the stronger binding of KIR3DL2 to B27 free H chain dimers. | J Immunol | 2015 | https://conductscience.org/library/papers/25582852 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| KIR3DL1 | 3811 | Swiss-Prot's references | https://conductscience.org/library/genes/3811 | NCBI Gene |
| KIR3DL2 | 3812 | Swiss-Prot's references | https://conductscience.org/library/genes/3812 | NCBI Gene |
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
| HLA-B | 3106 | PubTator's text mining | https://conductscience.org/library/genes/3106 | NCBI Gene |
| HLA-C | 3107 | PubTator's text mining | https://conductscience.org/library/genes/3107 | NCBI Gene |
| IGKV3D-20 | 28874 | PubTator's text mining | https://conductscience.org/library/genes/28874 | NCBI Gene |
| KIR2DL3 | 3804 | PubTator's text mining | https://conductscience.org/library/genes/3804 | NCBI Gene |
| UBASH3B | 84959 | PubTator's text mining | https://conductscience.org/library/genes/84959 | NCBI Gene |
Data5
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8760804
GET https://conductscience.org/api/papers/v1/8760804/references?page=2